IndiaMTF — home
Stock

DIVISLAB

Divi's Laboratories Limited
Health Technology

Daily Margin Trading Facility book for DIVISLAB across NSE and BSE, from 01 Jan 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹266 Cr
as of 10 Sep 2026
Rank in book
#132
407 days tracked
Share of book
0.17%
of the whole NSE + BSE book
Peak funded
₹266 Cr
on 10 Sep 2026
Largest single-day addition
+₹45 Cr
on 12 Aug 2026
Largest single-day unwind
−₹28 Cr
on 06 Jan 2026

NSE & BSE split

How DIVISLAB’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹264 Cr · 99.1%BSE ₹2 Cr · 0.9%

MTF vs Price

Margin-funded outstanding for DIVISLAB in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹9,322.00
as of 11 Sep 2026
Price, 30 days
+15.7%
adjusted for splits and bonuses
Delivery, 20-day avg
59.7%
of traded volume actually settled
Sessions to unwind
1.2
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day+₹7+2.8%+2.5%
+7,685
−0.5%building as it falls
10 days+₹22+9.0%+4.7%
+13,821
+4.2%building into strength
30 days+₹146+122.3%+84.8%
+1,41,624
+20.5%building into strength
90 days+₹182+217.8%+142.8%
+1,81,509
+42.2%building into strength
180 days+₹141+112.5%+58.3%
+1,13,709
+49.1%building into strength
1 year+₹140+111.2%+52.1%
+1,05,719
+53.1%building into strength
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where DIVISLAB has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

DIVISLAB — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 2026266+₹70.17%132
09 Sep 2026259+₹210.17%135
08 Sep 2026238−₹00.15%152
07 Sep 2026238+₹100.15%151
04 Sep 2026229+₹10.15%157
03 Sep 2026228+₹130.15%159
02 Sep 2026215−₹100.14%166
01 Sep 2026225−₹120.15%159
31 Aug 2026237−₹110.15%149
28 Aug 2026248+₹30.16%144
27 Aug 2026244+₹220.16%142
26 Aug 2026222−₹90.15%157
25 Aug 2026231−₹10.15%150
24 Aug 2026232−₹10.15%151
21 Aug 2026234+₹00.16%149
20 Aug 2026234+₹20.16%151
19 Aug 2026232+₹30.16%153
18 Aug 2026229−₹10.15%153
17 Aug 2026230−₹00.15%152
14 Aug 2026230+₹40.16%150
13 Aug 2026227+₹110.15%151
12 Aug 2026216+₹450.15%160
11 Aug 2026171+₹10.12%210
10 Aug 2026169+₹90.12%208
07 Aug 2026161+₹80.11%226
06 Aug 2026152+₹140.10%240
05 Aug 2026138−₹10.10%265
04 Aug 2026139+₹120.10%260
03 Aug 2026127+₹180.09%273
31 Jul 2026109—0.08%323

DIVISLAB within Health Technology

Ranked #6 of 61 funded Health Technology stocks, carrying 4.2% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
4ANURAS
Anupam Rasayan India Ltd
₹3816.0%
5SUNPHARMA
Sun Pharmaceutical Industries Limited
₹2804.4%
6DIVISLAB
Divi's Laboratories Limited
₹2664.2%
7GLAND
Gland Pharma Limited
₹2023.2%
8NATCOPHARM
Natco Pharma Limited
₹1903.0%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.